Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05946057

Otoferlin Patient Registry and Natural History Study

Patient Registry for Individuals With Otoferlin-Associated Hearing Loss

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Tobias Moser · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This registry is designed to collect comprehensive information about the molecular genetic diagnoses of individuals with otoferlin-associated hearing impairment and clinical information to support a natural history study.

Detailed description

A patient registry, in both German and English languages, has been established for patients with hereditary hearing impairment due to variants in otoferlin (OTOF). The study is conducted in accordance with the current version of the Declaration of Helsinki. The study protocol and database structure have been approved by the Ethics Committee of the University Medical Center Göttingen. Main objective criterion: To increase understanding of natural history, types of genetic variants and to facilitate clinical and basic research on otoferlin-associated hearing impairment. Secondary objective criterion: To improve knowledge to better characterize individuals with otoferlin-associated hearing impairment in the long term and create prerequisites for improved, patient tailored therapy and care.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMolecular genetic testing and audiometryGenetic testing and audiometry are the interventions of interest

Timeline

Start date
2023-02-21
Primary completion
2048-02-21
Completion
2048-02-21
First posted
2023-07-14
Last updated
2025-05-28

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05946057. Inclusion in this directory is not an endorsement.